These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15943987)

  • 1. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
    Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells.
    Abendstein B; Stadlmann S; Knabbe C; Buck M; Müller-Holzner E; Zeimet AG; Marth C; Obrist P; Krugmann J; Offner FA
    Cytokine; 2000 Jul; 12(7):1115-9. PubMed ID: 10880260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.
    Offner FA; Feichtinger H; Stadlmann S; Obrist P; Marth C; Klingler P; Grage B; Schmahl M; Knabbe C
    Am J Pathol; 1996 May; 148(5):1679-88. PubMed ID: 8623935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells.
    Zeimet AG; Offner FA; Marth C; Heim K; Feichtinger H; Daxenbichler G; Dapunt O
    Anticancer Res; 1997; 17(4B):3129-31. PubMed ID: 9329618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of human peritoneal mesothelial cells on angiogenesis factor expression and secretion of ovarian carcinoma cells].
    Zhang JJ; Wang B; Liu ZJ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):737-40. PubMed ID: 17366783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.
    Yoshino Y; Aoyagi M; Tamaki M; Duan L; Morimoto T; Ohno K
    Int J Oncol; 2006 Oct; 29(4):981-7. PubMed ID: 16964394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells.
    Offner FA; Obrist P; Stadlmann S; Feichtinger H; Klingler P; Herold M; Zwierzina H; Hittmair A; Mikuz G; Abendstein B
    Cytokine; 1995 Aug; 7(6):542-7. PubMed ID: 8580370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.
    Pérez-Ruiz M; Ros J; Morales-Ruiz M; Navasa M; Colmenero J; Ruiz-del-Arbol L; Cejudo P; Clária J; Rivera F; Arroyo V; Rodés J; Jiménez W
    Hepatology; 1999 Apr; 29(4):1057-63. PubMed ID: 10094946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
    Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta regulates vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts.
    Nasu K; Itoh H; Yuge A; Kawano Y; Yoshimatsu J; Narahara H
    Gynecol Endocrinol; 2006 Sep; 22(9):495-500. PubMed ID: 17071533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
    Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125.
    Zeimet AG; Marth C; Offner FA; Obrist P; Uhl-Steidl M; Feichtinger H; Stadlmann S; Daxenbichler G; Dapunt O
    Gynecol Oncol; 1996 Sep; 62(3):384-9. PubMed ID: 8812537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
    Zhang JJ; Wang B
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of human peritoneal mesothelial cells to inflammatory injury is regulated by interleukin-1beta and tumor necrosis factor-alpha.
    Stadlmann S; Pollheimer J; Renner K; Zeimet AG; Offner FA; Amberger A
    Wound Repair Regen; 2006; 14(2):187-94. PubMed ID: 16630108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of IL-10 in patients with ovarian carcinoma.
    Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
    Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
    Belotti D; Paganoni P; Manenti L; Garofalo A; Marchini S; Taraboletti G; Giavazzi R
    Cancer Res; 2003 Sep; 63(17):5224-9. PubMed ID: 14500349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.